Countries where the notices were issued: United States (43).
Name as written in the notices: Becton Dickinson & Co.; Becton Dickinson & Company. This is the brand or the responsible company as each authority recorded it. A recall shows a safety system working; it is not a verdict on a brand. Follow the official notice for each product.
| Date | Authority | Product | Hazard (as classified) |
|---|
| 2026-04-27 | US FDA — Medical Devices | BD Spinal Tray with BD Whitacre Needle 22 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL (0.75%) with dextrose ( | — |
| 2026-04-27 | US FDA — Medical Devices | BD Spinal Tray with BD Quincke Needle 26 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL (0.75%) with dextrose (8 | — |
| 2026-04-27 | US FDA — Medical Devices | BD Spinal Tray with BD Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL (0.75%) with dextrose ( | — |
| 2026-04-27 | US FDA — Medical Devices | BD Spinal Tray with BD Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL (0.75%) with dextrose ( | — |
| 2026-04-27 | US FDA — Medical Devices | BD Spinal Tray with BD Quincke Needle 25 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL (0.75%) with dextrose (8 | — |
| 2026-04-27 | US FDA — Medical Devices | BD Spinal Tray with BD Whitacre Needle 25 G x 3.5 in., BD Quincke Needle 22 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupiv | — |
| 2026-04-27 | US FDA — Medical Devices | BD Spinal Tray with BD Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 2 mL, bupivacaine HCL (0.75%) with dextrose ( | — |
| 2026-04-27 | US FDA — Medical Devices | BD Spinal Tray with BD Quincke Needle 22 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL (0.75%) with dextrose (8 | — |
| 2026-04-27 | US FDA — Medical Devices | BD Spinal Tray with BD Whitacre Needle 24 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL (0.75%) with dextrose ( | — |
| 2026-04-27 | US FDA — Medical Devices | BD Spinal Tray with BD Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL (0.75%) with dextrose ( | — |
| 2025-09-23 | US FDA — Medical Devices | BD EpiCenter Microbiology Data Management System, labeled as the following: 1. Computer System Epicenter F/G, Catalog | — |
| 2025-09-23 | US FDA — Medical Devices | BD BACTEC Blood Culture System, labeled as the following: 1. BACTEC 9120 System, Catalog Numbers: 445570, 445702. | — |
| 2024-10-31 | US FDA — Medical Devices | BD COR GX Instrument Version or Model: 443990 Catalog Number: 443990 | — |
| 2024-10-31 | US FDA — Medical Devices | BD Synapsys Informatics Solution (Laboratory Solution) Version or Model: 444150 Catalog Number: 444150 | — |
| 2024-10-31 | US FDA — Medical Devices | BD MAX System, BD MAX Instrument Version or Model: 441916 Catalog Number: 441916 | — |
| 2024-10-31 | US FDA — Medical Devices | BD BACTEC FX, Instrument Top, Packaged Version or Model: 441385 Catalog Number: 441385 | — |
| 2024-10-31 | US FDA — Medical Devices | BD EpiCenter Single User Software Version or Model: 441007 Catalog Number: 441007 | — |
| 2024-10-31 | US FDA — Medical Devices | BD EpiCenter Data Management System, Multi User Software Version or Model: 440981 Catalog Number: 440981 | — |
| 2024-10-31 | US FDA — Medical Devices | BACTEC 9240 System Version or Model: 445475 Catalog Number: 445475 | — |
| 2024-01-08 | US FDA — Medical Devices | BD BBL Sensi Disc Piperacillin/Tazobactam- 100/10 ug, used for semi-quantitative in vitro susceptibility testing. Catal | — |
| 2024-01-08 | US FDA — Medical Devices | BD BBL Sensi Disc Azithromycin -15 ¿g, Catalog Number 231682 used for semi-quantitative in vitro susceptibility testing. | — |
| 2024-01-08 | US FDA — Medical Devices | BD BBL Sensi Disc Rifampin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231541 and | — |
| 2024-01-08 | US FDA — Medical Devices | BD BBL Sensi Disc Cefpodoxime - 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231673 | — |
| 2024-01-08 | US FDA — Medical Devices | Sensi Disc Amoxicillin with Clavulanic Acid 20/10 ¿g, Catalog No. 231628 and 231629.¿ These discs are used for semi-q | — |
| 2024-01-08 | US FDA — Medical Devices | BD BBL Sensi Disc Minocycline - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 23125 | — |
| 2024-01-08 | US FDA — Medical Devices | BD BBL Sensi Disc Cefaclor - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231653 | — |
| 2024-01-08 | US FDA — Medical Devices | BD BBL Sensi Disc Cefotaxime - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231606 | — |
| 2024-01-08 | US FDA — Medical Devices | BD BBL Sensi Disc Tetracycline 30 ug,used for semi-quantitative in vitro susceptibility testing. Catalog Number 230998 a | — |
| 2024-01-08 | US FDA — Medical Devices | BD BBL Sensi Disc Meropenem- 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231703 an | — |
| 2024-01-08 | US FDA — Medical Devices | BD BBL Sensi Disc Ceftaroline - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 232231 | — |
| 2024-01-08 | US FDA — Medical Devices | BD BBL Sensi Disc Cefepime - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231696 | — |
| 2024-01-08 | US FDA — Medical Devices | BD BBL Sensi Disc Imipenem- 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231644 and | — |
| 2024-01-08 | US FDA — Medical Devices | BD BBL Sensi Disc Moxifloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231758 | — |
| 2024-01-08 | US FDA — Medical Devices | BD BBL Sensi Disc Chloramphenicol- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 230 | — |
| 2024-01-08 | US FDA — Medical Devices | BD BBL Sensi Disc Ertapenem- 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 232174 an | — |
| 2024-01-08 | US FDA — Medical Devices | BD BBL Sensi Disc Ciprofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231657 | — |
| 2024-01-08 | US FDA — Medical Devices | BD BBL Sensi Disc Aztreonam - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Numbers 231640 | — |
| 2024-01-08 | US FDA — Medical Devices | BD BBL Sensi Disc Levofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231705 | — |
| 2024-01-08 | US FDA — Medical Devices | BD BBL Sensi Disc Augmentin - 3µg, Catalog Number 291270 used for semi-quantitative in vitro susceptibility testing. | — |
| 2024-01-08 | US FDA — Medical Devices | BD BBL Sensi Disc Sulfamethoxazole with Trimethoprim 23.75/1.25 ug, used for semi-quantitative in vitro susceptibility t | — |
| 2024-01-08 | US FDA — Medical Devices | BD BBL Sensi Disc Ceftazidime- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231632 | — |
| 2024-01-08 | US FDA — Medical Devices | BD BBL Sensi Disc Ofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231672 | — |
| 2024-01-08 | US FDA — Medical Devices | BD BBL Sensi Disc Cefixime - 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231664 | — |